Lch. Park et al., Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy, J NEUROSC R, 66(5), 2001, pp. 1028-1034
Abnormalities in energy metabolism and oxidative stress accompany many neur
odegenerative diseases, including progressive supranuclear palsy (PSP). Pre
viously, we showed decreased activities of a mitochondrial enzyme complex,
alpha -ketoglutarate dehydrogenase complex (KG-DHC), and marked increases i
n tissue malondialdehyde levels in post-mortem superior frontal cortex from
the patients with PSP. The current study demonstrates that KGDHC is also s
ignificantly diminished (-58%) in the cerebellum from patients with PSP (n
= 14), compared to age-matched control brains (n = 13). In contrast to cort
ex, markers of oxidative stress, such as malondialdehyde, tyrosine nitratio
n or general protein carbonyl modification, did not increase in cerebellum.
Furthermore, the protein levels of the individual components of KGDHC did
not decline. The activities of two other mitochondrial enzymes were measure
d to determine whether the changes in KGDHC were selective. The activity of
aconitase, a mitochondrial enzyme with an iron/sulfur cluster, is also sig
nificantly diminished (-50%), whereas glutamate dehydrogenase activity is u
nchanged. The present results suggest that the interaction of metabolic imp
airment and oxidative stress is region-specific in PSP brain. In cerebellum
, reductions in KGDHC occur in the absence of increases in common measures
of oxidative stress, and may underlie the metabolic deficits and contribute
to pathological and clinical manifestation related to the cerebellum in pa
tients with PSP. (C) 2001 Wiley-Liss, Inc.